AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
19 Diciembre 2024 - 4:00PM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative
medical technology company focused on restoring healthy blood flow
in the body’s vascular system, expanding cancer treatment options
and improving patient quality of life, today announced that it will
report financial results for the second quarter of fiscal year 2025
before the market open on Wednesday, January 8, 2025, followed by a
Virtual NanoKnife System investor event.
Fiscal 2025 Second Quarter Financial Results Conference
Call
The Company’s management will host a conference call at 8:00 am
ET the same day to discuss the results.
To participate in the conference call, dial 1-877-407-0784
(domestic) or +1-201-689-8560 (international).
This conference call will also be webcast and can be accessed
from the “Investors” section of the AngioDynamics website at
www.angiodynamics.com. The webcast replay of the call will be
available at the same site approximately one hour after the end of
the call.
A recording of the call will also be available, until Wednesday,
January 15, 2025 at 11:59 PM ET. To hear this recording, dial
1-844-512-2921 (domestic) or +1-412-317-6671 (international) and
enter the passcode 13750571.
Virtual NanoKnife Investor Event
In an effort to provide investors more insight into the
NanoKnife System and the Company’s strategy for the technology, the
Company will be hosting a virtual investor event on January 8, 2025
at 9:30am ET.
This event be webcast and can be accessed from the “Investors”
section of the AngioDynamics website at www.angiodynamics.com.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology
company focused on restoring healthy blood flow in the body’s
vascular system, expanding cancer treatment options and improving
quality of life for patients.
The Company’s innovative technologies and devices are chosen by
talented physicians in fast-growing healthcare markets to treat
unmet patient needs. For more information, visit
www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241219061676/en/
Investors: AngioDynamics, Inc. Stephen Trowbridge, Executive
Vice President & CFO (518) 795-1408
AngioDynamics (NASDAQ:ANGO)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
AngioDynamics (NASDAQ:ANGO)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
